# Nasdaq's Wild Ride: Splits, Stocks, and Surprises! Newsy: Bud Fox's 3 Controversial Stocks of the Day Published: 2026-07-28T14:00:00.202Z Source: https://newsyai.com/edition/9d018c40-af2f-4c1b-9edb-6f907e6ca9fa Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md --- **Nasdaq’s Reverse-Split Roulette: Cannabis Clouds, German Gels & the MVLS Meat Grinder – July 28, 2026 Edition!** Futures mixed (Dow napping, Nasdaq still high on AI/chip fumes while crude oil struts like it owns the pump). Yesterday’s STKH/AMZE/SBEV split circus? Yesterday’s news. The Nasdaq meat grinder keeps churning with the shiny new $5M MVLS rule—no more endless cure periods for the walking dead. Repeat offenders get the delisting boot faster than a bad earnings call. Balls-deep into three fresh volatility junkies where bulls and bears are yelling louder than a packed trading floor. ### 1) Auxly Cannabis Group Inc. (XLY / 3KF): “14-for-1 Cannabis Comeback Fantasy vs. Chronic Cash Burn & Dilution Doom” **Why it’s loud** 14-for-1 reverse split effective today for compliance. Canadian cannabis play hyped on wellness products, extracts, and international expansion. Bulls eye any regulatory win or sales spike with the shrunken float; bears hammer ongoing losses, weak margins, and “weed bomb” history.[[1]](https://finance.yahoo.com/calendar/splits/) **Bull case (compliance rocket + green stiffy)** Massive ratio + volume pop + any legalization tailwind = $1–5+ rip. Ride the cannabis comeback fantasy, degens—tiny float turns rumors into rocket fuel! **Bear case (dilution gangbang & split limp encore)** 14x desperation screams endless capital hunger, brutal competition from bigger players, repeated raises = sub-$0.05 graveyard. Short the fade before the next offering tsunami! **My take, first principles (real market signal vs. listing cancer)** Genuine niche in alternative wellness offers short-term narrative juice, but scaling headaches, dilution history, stricter Nasdaq MVLS scrutiny, and microcap chaos scream unsustainable trap. Real operational moonshot with lottery vibes. Scalp the spunk? **$0.08–2.40** range, **$0.55C** green pump—**P$0.06** dilution fade. ### 2) Bio-Gate AG (BIG1): “5-for-1 Medical Tech Hype vs. European Execution Risks & Tiny Float Madness” **Why it’s loud** 5-for-1 reverse split effective today amid compliance push. German biotech play focused on antimicrobial coatings and medical device tech. Bulls drool over any partnership or regulatory nod with the post-split float; bears pound limited U.S. traction, cash burn, and “euro zombie” vibes.[[1]](https://finance.yahoo.com/calendar/splits/) **Bull case (compliance rocket + med-tech boner)** Decent ratio + volume spike + any health-tech deal = $1–4+ rip. Ride the antimicrobial fantasy, apes! **Bear case (dilution gangbang & split limp encore)** 5x desperation screams capital needs, brutal sector competition, repeated raises = sub-$0.08 cemetery. Short the fade before the next offering tsunami! **My take, first principles (real tech signal vs. listing cancer)** Genuine low-float medical coatings appeal offers short-term hype juice, but execution risks abroad, dilution overhang, new MVLS rules, and microcap volatility scream trap. Real operational niche with token risk. Scalp it? **$0.10–2.10** range, **$0.50C** med-tech pump—**P$0.07** dilution fade. ### 3) KR Motors Co Ltd (000040.KQ): “5-for-1 Korean EV/Mobility Dream vs. Global Competition & Governance Red Flags” **Why it’s loud** 5-for-1 reverse split effective today. Korean mobility play hyped on electric vehicles and transport tech. Bulls eye any EV tailwind or partnership with the shrunken float; bears hammer fierce global competition, thin margins, and “Asian microcap” volatility history.[[1]](https://finance.yahoo.com/calendar/splits/) **Bull case (compliance rocket + EV stiffy)** Solid ratio + volume spike + any mobility news = $1–4+ rip. Ride the EV fantasy, degens! **Bear case (dilution gangbang & split limp encore)** 5x desperation screams capital hunger, brutal EV wars, repeated raises = sub-$0.05 graveyard. Short the fade before the next offering tsunami! **My take, first principles (real mobility signal vs. listing cancer)** Genuine EV/mobility narrative offers short-term hype juice, but competition nightmares, dilution history, stricter Nasdaq MVLS scrutiny (even on cross-listed plays), and microcap chaos scream unsustainable trap. Real operational moonshot with lottery vibes. Scalp the spunk? **$0.09–1.90** range, **$0.45C** EV pump—**P$0.06** dilution fade. **Tape-Side Tactics (XLY Cannabis Clouds, BIG1 German Gels & KR Motors EV Mayhem – July 28 Edition)** - **XLY**: **$0.08–2.40** stiffy; **$0.55C** green pump, **P$0.06** fade. - **BIG1**: **$0.10–2.10** stiffy; **$0.50C** med-tech pump, **P$0.07** fade. - **000040.KQ**: **$0.09–1.90** stiffy; **$0.45C** EV pump, **P$0.06** fade. New MVLS rules still tightening the noose amid crude cock-up and micro-madness. Balls-deep DYOR, NFA, degens duck the dilutions! **Sources** (for tracking every claim above): - Reverse splits & reactions: Yahoo Finance Stock Splits Calendar (July 28, 2026 data). - Company announcements & details: Company filings, press releases via GlobeNewswire/PR Newswire equivalents. - Nasdaq reverse-split rule changes & MVLS: SEC filings, Nasdaq Listing Rules (2026 updates). - Broader microcap/premarket context & volatility: Yahoo Finance, recent market data.